Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Hypera SA
ISIN BRHYPEACNOR0
|WKN A0Q65D
Market cap (in EUR)
3,096 m
Country
Brazil
Sector
Healthcare
Dividend yield
4.93%
Overview
Description
Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. It operates through the following segments: Prescription Products, Consumer Health, Similar and Generic Drugs, Skincare, and Institutional Market. The company was founded by João Alves de Queiroz Filho on December 1, 2001 and is headquartered in Sao Paulo, Brazil.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Brazil
Financials
Key metrics
| Market capitalisation, EUR | 3,096 m |
| EPS, EUR | 0.30 |
| P/B ratio | 1.2 |
| P/E ratio | 12.6 |
| Dividend yield | 4.93% |
Income statement (2025)
| Revenue, EUR | 1,222 m |
| Net income, EUR | 190 m |
| Profit margin | 15.53% |
What ETF is Hypera SA in?
There are 18 ETFs which contain Hypera SA. All of these ETFs are listed in the table below. The ETF with the largest weighting of Hypera SA is the iShares MSCI Emerging Markets Small Cap UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.